1Manjunath AP,Pratapkumar AP,Sujatha K,et al.Comparison of three risk of malignancy indices in evaluation of pelvic masses[J].Gynecol Oncol,2001,81:225-229.
2Jacobs I,Oram D,Fairbanks J,et al.A risk of malignancy index incorporating CA125,ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer[J].Br J Obstet Gynaecol,1990,97:922-929.
2Leon Speroff. The perimenopause definitions,demography, and physiology. Obstet Gynecol Clin N Am, 2002,29:397-410.
3Hervy E, HoA N. The role of prophylactic oophorectomy in cancer prevention. Gynecol Oncol, 1994,55 :S38-S41.
4Reich H. Issues surrounding surgical menopause indications and procedures. J Reprod Med,2001,46 : 297-306.
5Leeper K,Garcia R,Swisher E, et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol,2002,87:52-56.
6Parazzini F, Negri E, Vecchia C, et al. Hysterectomy, oophorectomy,and subsequent ovarian cancer risk. Obstet Gynecol, 1993,81 (3):363 -366.
7Rebbeck TR. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. J Oncol Clin,2000,18:100s-103s.
8Schwartz PE. The role of prophylactic oophorectomy in the avoidance of ovarian cancer. Int J Gynecol Obstet, 1992,39 : 175-184.
9Steven A, Boyd J. Current understanding of the epidemiology andclinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr Opin Obstet Gyneco1,2002,14 : 19-26.
10Dekel A, Efrat Z,Orvieto R, et al. The residual ovary syndrome a 20-year experience. E J Obstet Gynecol Reprod Biol, 1996,68:159-164.
2Yoruk P, Dundar O, Yildizhan B,et al. Comparison of the risk of malignancy index and self-constructed logistic regression models in preoperative evaluation of adnexal masses[J]. Journal of Ultrasound in Medicine, 2008,27(10) : 1469-1477.
3Chia YN, Marsden DE, Robertson G, et al. Triage of ovarian masses[J]? The Australian and New Zealand Journal of Obstet- rics and Gynecology, 2008,48 (3) : 322-328.
